Home Physician Samples Order Links Ocuwel
Age-Related Macular Degeneration
How Ocuwel Can Help
Introductory Offer and Discounts
Important News
Other Products
Contact Us

Sheltowee Pharmaceuticals

Abstract From the Journal of the American Optometric Association:

Part II:: ARMD- Pilot (Case Series)
environmental intervention data

Dr. Stuart Richer, O.D.

Background:
A description and justification for using a standardized clinical low-cost, "low-technology", ocular and systemic "ARMD work-up" protocol was presented in the methods paper (part I).

Methods:
Fourteen male patients (70+-9 years), receiving .73+- .43 portions of dark-green, leafy vegetables/day base intake, were placed on an additional portion of 5 ounces sautéed spinach 4 to 7 times per week or lutein based anti-oxidant (three patients). : Detailed "ARMD work-up" data for six of these patients and summary pilot (case series) environmental intervention data are presented.

Results:
One, patients demonstrated short-term positive effects in visual function in one or both eyes with this mild therapeutic approach:: Amsler grid (87%); Snellen Acuity (71%); Contrast sensitivity (92%); SKILL (65%); Glare recovery (69%); and Activities of Daily Vision Subscale (60%); Two, There was no obvious correlation between opthalmoscopic appearance of the retina and visual outcome; and Three, Patient symptoms did not necessarily correlate with observed changes in visual function.

Conclusions:
The approach to atrophic ARMD presented here warrants informal practitioner replication and formal randomized prospective clinical case-control evaluation.

J. Am. Optom. Assoc.: 1999; 70: 24-36


Copyright © 1998-2001 Sheltowee, LLC.  All Rights Reserved.
Ocuwel® is a registered trademark of Audax, Inc.
Ocuwel is distributed by Sheltowee, LLC.
Toll-free: 1-888-935-5393 - Fax: 1-520-832-2308
E-mail: Info@SheltoweeLLC.com
Sheltowee, LLC - 1044 E. Chestnut St. - Louisville, KY  40202


Ocuwel